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Emerging research on severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) shows that it is spreading
to multiple organs in addition to the respiratory system. Though the SARS-CoV2 enters the human body by
binding to ACE2 receptors on pulmonary alveolar cells, recent studies indicate that it is spreading to the central
nervous system, cardiac and skeletal muscles leading to various pathological conditions in these organs. In
particular, the effects of SARS-CoV-2 on triggering the cytokine storm and its consequential effects on skeletal
muscles has generated a lot of discussion. The effects of this virus on muscular function especially in susceptible
elderly populations is still being explored. However, its effects on diaphragm, a respiratory muscle which plays an
important role in determining lung capacity are not completely explored. Currently, as new evidence on using
lung ultrasounds to conﬁrm COVID-19 diagnosis is gaining traction, it is necessary to explore the role of diaphragm in treating COVID-19 patients. This article will review the effects of cytokine storm triggered by the SARSCoV-2 and its resultant effects on skeletal muscle with a speciﬁc focus on the diaphragm in order to identify
knowledge gaps in effectively treating COVID-19 patients, especially those who are on a mechanical ventilator.

1. Introduction
Coronavirus disease-2019 (COVID-19) which began in December
2019 in China has caused an unprecedented global pandemic posing the
most serious threat to global health. Though not much was known about
COVID-19 in the beginning, the past year provided critical insights in
understanding the speciﬁc nature of this SARS-CoV-2 virus. According to
the World Health Organization (WHO), this virus has affected 119.6
million people that resulted in more than 2.64 million deaths around the
world by March 15th, 2021 (Coronavirus disease (, 2019). It is now
established that SARS-CoV-2 uses the angiotensin converting enzyme 2
(ACE2) as a functional receptor for its entry into pulmonary alveolar cells
and induces acute respiratory distress syndrome (ARDS), a
life-threatening condition characterized by poor oxygenation and pulmonary inﬁltration (Gheblawi et al., 2020). As a membrane protein ACE2
is widely distributed in multiple organs including the skeletal muscles
(Chappell, 2021). Several studies on mouse limb muscle and human
diaphragm have clearly shown the ACE2 expression on their cell membranes (Giordani et al., 2019; Shi et al., 2020). As the largest organ of the
human body, skeletal muscle has the ability to produce and release a
number of cytokines known as myokines. When the SARS-CoV-2 enters

the circulatory system and reaches skeletal muscle cells, it interacts with
ACE2 receptors on their cell membranes. Numerous studies have shown
that myokines like TNFα, IL-6, IL-8, IL-10, and IFNγ are released in
response to diverse physiological and pathophysiological conditions
€rgens et al., 2015; Hallberg et al., 2010; Peake et al., 2015). These
(Go
myokines then act in endocrine, paracrine or autocrine manner on
multiple organs which may in turn initiate immune response (Pedersen
and Febbraio, 2008; Pedersen, 1985).
Skeletal muscles are rich in proteins and mitochondria and therefore
more prone to undergo loss of their mass or function in response to either
metabolic stress or pathological conditions. Diaphragm, one of the
essential skeletal muscles of the respiratory system, plays a key role in
maintaining lung capacity and any decline in its function can lead to
decreased respiratory efﬁciency. With increasing age, sarcopenia is more
evident with changes in morphological features that make these muscles
less elastic with a lower shortening speed. Diaphragm also undergoes this
age-related decline in its structure and function. Data from animal
models and clinical studies show that the diaphragm is highly sensitive to
shock. For example, sepsis like condition has shown to reduce the lung's
ability to produce inspiratory pressure (Demoule et al., 2013). Clinical
studies demonstrate that patients with sepsis conditions often need
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gastrocnemius muscle (Vassilakopoulos et al., 2004). Increased levels of
IL-6 in diaphragm was further conﬁrmed by immunoblotting as well as
immunostaining (Vassilakopoulos et al., 2004). These studies demonstrate the role of diaphragm in producing cytokines during strenuous
breathing. Similar to animal studies, increases in the pro-inﬂammatory
cytokine expression (TNFα, IL-1β, and IL-6) were observed in the
external intercostal muscles of COPD patients as well (Casadevall et al.,
2007).
In contrast to primary sarcopenia, Duchenne muscular dystrophy
(DMD) is a severe, progressive, muscle-wasting genetic disorder of the
younger patients. Studies conducted on DMD patients and dystrophic
mice highlighted the relationship between cytokine (i.e. IL-6) and redox
balance in diaphragm muscle of both DMD patients and dystrophic mice
(Petrillo et al., 2017). More speciﬁcally, Petrillo et al., has demonstrated
that IL-6 overexpression in transgenic mouse model parallels the antioxidant expression proﬁle and the severity of dystrophic muscle observed
in DMD patients (Petrillo et al., 2017). Data from dystrophic mice show
that deregulated levels of IL-6 alters the local and systemic redox
signaling markers. In addition, IL-6 also acts as a central player in disturbing the redox balance in the diaphragm (Pelosi et al., 2017). In
support of these ﬁndings, another study demonstrated that overexpression of circulating IL-6 enhances the generation and accumulation
of free radicals in the diaphragm that leads to skeletal muscle atrophy in
adult transgenic mice (Forcina et al., 2019).
Overall, these studies indicate that oxidative stress, inﬂammation and
cytokines are closely related to each other and coexist in a muscle
environment under diverse clinical settings. For example, a study conducted in rats demonstrated that during resistive breathing the production of nitric oxide decreased inside the diaphragm which in turn
contributed to intra-diaphragmatic up-regulation of cytokines (IL-6, IL10, IL-2, TNFα, and IL-1β). However, when nitric oxide is supplemented this response is downregulated. Available data also demonstrate
that cytokines are differentially regulated by different signaling pathways i.e. IL-10, IL-2, TNFα, and IL-1β are regulated NF-κB dependent
pathways (muscle atrophy-related transcription factor) while IL-6 is
regulated by a pathway independent of NF-κB (Sigala et al., 1985).

mechanical ventilation for their survival. Available literature also illustrates that mechanical ventilation acts as a two-edged sword associated
with progressive development of diaphragm atrophy and
ventilator-induced diaphragmatic dysfunction (VIDD) while providing
the much-needed mechanical ventilation (Maes et al., 2014; Levine et al.,
2008). During the ARDS condition, the preserved diaphragmatic activity
is associated with a reduced risk of VIDD. Thus, assisted spontaneous
breathing is considered the most appropriate physiologic method of
respiratory support (Russotto et al., 2018).
Surprisingly, a time-dependent decrease of diaphragm strength after
initiation of mechanical ventilation, has gained much research interest
while diaphragm dysfunction at the onset of critical illness did not
receive due attention (Petrof et al., 2010). Though more than 3000 articles on cytokine storm and the role of skeletal muscles in COVID-19 are
published by March 15th, 2021, only 24 articles investigated its effects
on diaphragm. Therefore, this paper will provide a research update on
the role of cytokine storm and skeletal muscles in COVID-19 disease and
then provide some insights into the knowledge gaps speciﬁcally related
to diaphragm that needs to be explored in order to optimize care for
elderly COVID-19 patients in need of a mechanical ventilator.
2. Cytokine storm and the diaphragm
Cytokine storm is a cascade of auto-amplifying cytokine production
due to unregulated immune response of the host to different triggers like
infection or malignancy. In COVID-19 patients, this uncontrolled
abnormal immune response results in attacking its own cells and tissues
instead of the virus particles leading to multiorgan failure and ultimately
death. Recent studies have already shown that patients with COVID-19
have higher concentration of these proinﬂammatory cytokines (Ragab
et al., 2020). In their review of current evidence and treatment strategies
for COVID-19, Tang et al., summarizes other studies that indicate poor
prognosis in patients with higher levels of these cytokines (Tang et al.,
2020). As most COVID-19 patients report skeletal muscle weakness and
fatigue coupled with the fact that ACE2 receptors are located on these
muscle membranes, it is plausible that skeletal muscles especially diaphragm plays a critical role in patient prognosis.
Further, when COVID-19 mortality risk is calculated across the age
groups, about 70% of all COVID-19 deaths in USA are from the age group
of 70 years and above (Goldstein and Lee, 2020). Therefore, primary
sarcopenia which is an age-related decrease in skeletal muscle function
and muscle mass is a critical factor in understanding cytokine storm in
older COVID-19 patients. Primary sarcopenia is generally associated with
a decline in motor activity, cognitive function, respiratory function and
immune senescence in older adults and cancer patients. Based on these
characteristics, a number of studies have speculated that patients with
sarcopenia and COVID-19 will have greater respiratory disease severity,
and elevated mortality rates (Welch et al., 2020; Morley et al., 2020;
Wang et al., 2021). However, so far there were no direct studies that
investigated the relationship between sarcopenia and COVID-19 in older
patients. The only direct evidence connecting weight loss, increase in
inﬂammatory cytokines and COVID-19 comes from two animal studies
conducted on Syrian hamsters and mice (Lau et al., 2020; Chan et al.,
2020; Sheahan et al., 2020).
Previous mechanistic studies conducted on healthy volunteers
demonstrated that sepsis induced changes in the diaphragm are due to
excessive production of proinﬂammatory cytokines, free-radical generation, and activation of the diverse proteolytic systems (Vassilakopoulos
et al., 2002). Studies show that oxidative stress is a major stimulus for the
cytokines production under inspiratory resistive breathing conditions
where monocytes do not play any role (Vassilakopoulos et al., 2002).
This is supported by another study conducted on rats which documented
gene expression of different cytokines in diaphragm and showed that
strenuous sensitive breathing induces plasma cytokines. Data from this
study on normal rats also show that IL-6, IL-1β, TNFα, IL-10, IFNγ, IL-4
cytokines mRNA levels were high in diaphragm but not in

3. Skeletal muscle function in COVID-19
From the available COVID-19 related literature, we found two ideas
that need further investigation. The ﬁrst idea requires exploring the
cytokine storm to identify potential targets for intervention. For example,
IL-6 blockade has been reported to be in use in China for COVID-19 patients as an increase in the level of IL-6 has also been reported in these
patients, suggesting its crucial role in cytokine storm (Ruan et al., 2020;
Liu et al., 2020). Another approach is to target the oxidative stress
pathway. An extracellular superoxide dismutase, an antioxidant enzyme
released by muscle due to regular exercise, may reduce the risk of acute
respiratory distress syndrome (ARDS) in COVID-19 patients (Yan and
Spaulding, 2020). Further, a new clinical trial to use antioxidant vitamin
c against oxidative stress induced tissue damage for COVID-19 patients
has begun in Wuhan, China (Carr, 2020). A recent study on COVID-19
patients has conﬁrmed skeletal muscle injury in these patients that
correlated with an increase in creatinine kinase levels in their blood (Mao
et al., 2020). Therefore, speciﬁc studies on using creatinine kinase levels
in blood as an early biomarker for COVID-19 could be very helpful in long
term care for the patients.
The second idea requires optimizing the conditions for using mechanical ventilation. Prolonged intensive care unit (ICU) stay is required
for stabilization of COVID-19 patients and that may itself directly impact
loss of skeletal muscle mass and function which may further add on to
human morbidity (Barazzoni et al., 2020). Available clinical reports
clearly illustrate that prolonged mechanical ventilation is associated with
gradual development of diaphragm atrophy and ventilator-induced diaphragmatic dysfunction (VIDD) (Vassilakopoulos and Petrof, 2004). To
prevent or reverse VIDD, United States FDA approved lung pacer
2
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Fig. 1. Graphical abstract showing the interaction between SARS-CoV2, cytokine storm and the diaphragm.

● Re-evaluate the optimal conditions of the mechanical ventilators by
considering effects of sarcopenia when using them in elderly COVID19 patients. As multi organ failure is common in these patients,
studies on chest radiography in addition to cardiac and vascular ultrasounds must be explored to have a comprehensive understanding
on clinical management of COVID-19 patients on ventilators. Though
the effects of nitric oxide on cytokines levels in rat diaphragm were
studied before the COVID-19 pandemic, further studies exploring
their role in treating COVID-19 patients especially those on ventilator
are warranted.

diaphragm pacing therapy system for COVID-19 patients in April 2020.
Recent studies on COVID-19 ICU patients have provided clear histological evidence for ACE-2 expression and SARS-CoV-2 inﬁltration in to the
diaphragm that ultimately leads to development of ﬁbrosis (Shi et al.,
2021). In addition, diagnostic tests like lung ultrasound are currently
used to assess diaphragm function in COVID-19 patients and manage
their weaning process (Guarracino et al., 2021).
These observations strongly emphasize the signiﬁcance of skeletal
muscles in the treatment of ARDS associated with COVID-19. The SARSCoV-2 enters the body through the respiratory system and then gradually
enters the circulatory system. As ACE2 receptors are widely distributed in
all the tissues, the virus enters other organs especially like skeletal
muscles that are likely to trigger the cytokine storm [Fig. 1]. Based on the
current knowledge of SARS-CoV-2 pathology and its clinical manifestations, the search for speciﬁc antivirals along with immune-modulating
drugs must include supplemental drugs that act on the skeletal muscles
especially the diaphragm. This two-pronged approach will not only
minimize the multiorgan failure by controlling the cytokine storm but
also enhance the recovery of patients on mechanical ventilators by
improving diaphragm function.

Completion of the above-mentioned studies will provide a foundational basis to identify therapeutic targets and develop a potential
treatment plans for COVID-19 patients. This is necessary as the currently
available COVID-19 vaccines will protect people from the effects of
SARS-CoV-2 but not helpful in treating COVID-19 patients.
CRediT authorship contribution statement
Ashwani Mittal: Conceptualization, Writing – original draft. Anita
Dua: Data curation, Visualization. Sanjeev Gupta: Resources, Project
administration. Elisha Injeti: Investigation, Conceptualization, Writing –
review & editing.

4. Conclusion
The current literature and clinical data on the role of diaphragm in
COVID-19 patients indicate a complex interplay between SARS-CoV-2
mediated lung injury, cytokines storm, ARDS, ventilator, and aging
which eventually becomes fatal to the susceptible patient. Diaphragm not
only is in the center of such correlation but is critically important during
ICU where the patients are on ventilators. Based on our review of
available COVID-19 literature, we identified the following knowledge
gaps that require further investigation:
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